Ra mắt thuốc kháng thể chống COVID-19 có hiệu quả bảo vệ trong 6 tháng

Ngày 18/11, hãng dược phẩm AstraZeneca (Anh-Thụy Điển) cho biết thuốc kháng thể chống COVID-19 dạng tiêm mang tên Evusheld của hãng này cho hiệu quả bảo vệ lên đến 83% trong vòng 6 tháng.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Thượng viện Mỹ phản đối siết quyền của tổng thống Trump trong cuộc chiến với Iran

Thượng viện Mỹ phản đối siết quyền của tổng thống Trump trong cuộc chiến với Iran

Thế giới
(Baothanhhoa.vn) - Thượng viện Mỹ đã bỏ phiếu bác Nghị quyết Quyền hạn Chiến tranh với tỷ lệ 47 phiếu thuận và 53 phiếu chống, qua đó không thông qua đề xuất yêu cầu Tổng thống Mỹ phải có sự chấp thuận của Quốc hội trước khi tiến hành các đợt tấn công tiếp theo nhằm vào Iran.
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh